Gryphon Financial Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,198
| Closed | -$264K | – | 258 |
|
|
2024
Q3 | $264K | Buy |
4,198
+145
| +4% | +$9.12K | 0.04% | 249 |
|
|
2024
Q2 | $239K | Sell |
4,053
-1,025
| -20% | -$60.5K | 0.04% | 246 |
|
|
2024
Q1 | $405K | Sell |
5,078
-3,073
| -38% | -$245K | 0.07% | 181 |
|
|
2023
Q4 | $654K | Buy |
8,151
+2,653
| +48% | +$213K | 0.12% | 121 |
|
|
2023
Q3 | $384K | Sell |
5,498
-188
| -3% | -$13.1K | 0.09% | 115 |
|
|
2023
Q2 | $393K | Sell |
5,686
-548
| -9% | -$37.9K | 0.09% | 121 |
|
|
2023
Q1 | $463K | Sell |
6,234
-360
| -5% | -$26.8K | 0.11% | 105 |
|
|
2022
Q4 | $614K | Sell |
6,594
-1,063
| -14% | -$99.1K | 0.15% | 81 |
|
|
2022
Q3 | $730K | Buy |
7,657
+2,218
| +41% | +$211K | 0.18% | 63 |
|
|
2022
Q2 | $504K | Buy |
5,439
+318
| +6% | +$29.5K | 0.12% | 97 |
|
|
2022
Q1 | $518K | Buy |
5,121
+37
| +0.7% | +$3.74K | 0.11% | 105 |
|
|
2021
Q4 | $525K | Buy |
5,084
+99
| +2% | +$10.2K | 0.1% | 119 |
|
|
2021
Q3 | $424K | Sell |
4,985
-142
| -3% | -$12.1K | 0.09% | 118 |
|
|
2021
Q2 | $381K | Sell |
5,127
-2
| -0% | -$149 | 0.09% | 124 |
|
|
2021
Q1 | $386K | Buy |
5,129
+112
| +2% | +$8.43K | 0.09% | 120 |
|
|
2020
Q4 | $343K | Buy |
5,017
+262
| +6% | +$17.9K | 0.09% | 116 |
|
|
2020
Q3 | $278K | Buy |
+4,755
| New | +$278K | 0.08% | 124 |
|
|
2020
Q2 | – | Sell |
-4,196
| Closed | -$249K | – | 139 |
|
|
2020
Q1 | $249K | Buy |
4,196
+39
| +0.9% | +$2.31K | 0.09% | 120 |
|
|
2019
Q4 | $308K | Sell |
4,157
-19
| -0.5% | -$1.41K | 0.08% | 134 |
|
|
2019
Q3 | $264K | Buy |
+4,176
| New | +$264K | 0.08% | 138 |
|
|
2018
Q3 | – | Sell |
-491
| Closed | -$32K | – | 308 |
|
|
2018
Q2 | $32K | Buy |
491
+104
| +27% | +$6.78K | 0.01% | 301 |
|
|
2018
Q1 | $24K | Sell |
387
-148
| -28% | -$9.18K | 0.01% | 352 |
|
|
2017
Q4 | $39K | Buy |
+535
| New | +$39K | 0.02% | 290 |
|